Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

npj Precision Oncology, 2025
Plasma proteomic biomarkers predict therapeutic responses in advanced biliary tract cancer patients receiving Camrelizumab plus the GEMOX treatment

Cui S., Zheng H., Xu Y. et al.

Olink Target 96OncologyImmunotherapyPatient StratificationPlasma

Arthritis & Rheumatology, 2025
Serum Proteomic Signatures Before the Diagnosis of Rheumatoid Arthritis: Evolving Biologic Pathways and Specific Periods of Disease Development

Rachid Zaim S., Savage A., Gillespie M. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPatient StratificationSerum

Cell Genomics, 2025
Integration of biobank-scale genetics and plasma proteomics reveals evidence for causal processes in asthma risk and heterogeneity

Donoghue L., Benner C., Chang D. et al.

Olink Explore 3072/384Immunological & Inflammatory DiseasesPathophysiologyPlasma

Cell Reports Medicine, 2025
Altered baseline immunological state and impaired immune response to SARS-CoV-2 mRNA vaccination in lung transplant recipients

Hu M., Oliveira A., Fang Z. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma

Mediators of Inflammation, 2025
Causal Associations of Inflammatory Cytokines With Osteosarcopenia: Insights From Mendelian Randomization and Single Cell Analysis

Wu Z., Yang J., Zhu Y. et al.

Olink Target 96AgingPathophysiologyPlasma

Neurological Research, 2025
Mediators of the causal associations between protein ratios and ischemic stroke: a two-step Mendelian randomization study

Tan H., Chen H., Yan H. et al.

Olink Explore 3072/384NeurologyPathophysiologyPlasma

International Journal of Cancer, 2025
Prospective evaluation of 92 protein biomarkers for early detection of endometrial cancer

Cooley V., Fortner R., Mukama T. et al.

Olink Target 96OncologyPatient StratificationPlasma

Nature Medicine, 2025
Immune and metabolic effects of African heritage diets versus Western diets in men: a randomized controlled trial

Temba G., Pecht T., Kullaya V. et al.

Olink Target 96Nutritional SciencePathophysiologyPlasma

Journal of Proteome Research, 2025
Identification of Salivary Biomarkers in Colorectal Cancer by Integrating Olink Proteomics and Metabolomics

Su H., Gu X., Zhang W. et al.

Olink Target 96OncologyPatient StratificationSaliva

Urolithiasis, 2025
Effect of the plasma metabolites, biomarkers, and inflammatory proteins on urolithiasis: insights from Mendelian randomization and mediation analysis

Huang H., Wen Z., Li H. et al.

Olink Target 96UrologyPathophysiologyPlasma

Diabetes Care, 2025
Large-Scale Proteomics Improve Risk Prediction for Type 2 Diabetes

Xie R., Vlaski T., Trares K. et al.

Olink Target 96Olink Explore 3072/384Metabolic DiseasesPatient StratificationPlasma

Cell Reports, 2025
Long-lasting antibody B-cell responses to SARS-CoV-2 three years after the onset of the pandemic

Molinos-Albert L., Rubio R., Martín-Pérez C. et al.

Olink Target 96Infectious DiseasesPathophysiologyPlasma

Proceedings of the National Academy of Sciences, 2025
Nuclear Galectin-1 promotes KRAS -dependent activation of pancreatic cancer stellate cells

Vinaixa J., Martínez-Bosch N., Gibert J. et al.

Olink Target 96OncologyPathophysiologyCell Culture Supernatant

Cell Reports Medicine, 2025
TIMEPOINT, a phase 1 study combining MTL-CEBPA with pembrolizumab, supports the immunomodulatory effect of MTL-CEBPA in solid tumors

Plummer R., Sodergren M., Hodgson R. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPlasma

Annals of Laboratory Medicine, 2025
Pancreatic Cancer Detection and Differentiation from Chronic Pancreatitis: Potential Biomarkers Identified through a High-Throughput Multiplex Proteomic Assay and Machine Learning-Based Analysis

Kim Y., Kim S., Lee S.

Olink Target 96OncologyPatient StratificationSerum

Discover Oncology, 2025
Appraising the causal role of cathepsins in genitourinary carcinoma: a two-sample mendelian randomization and prospective study based on 36,225 individuals

Zhu Q., Liu D., Liu H. et al.

Olink Explore 3072/384OncologyPathophysiologyPlasma

Annals of Clinical and Translational Neurology, 2025
CSF Tau Is a Biomarker of Hippocampal Injury in Cryptogenic New‐Onset Refractory Status Epilepticus

Goh Y., Jang Y., Shin S. et al.

Olink Target 96Olink Target 48NeurologyPatient StratificationPlasmaCSF

PLOS Computational Biology, 2025
Putting computational models of immunity to the test—An invited challenge to predict B.pertussis vaccination responses

Shinde P., Willemsen L., Anderson M. et al.

Olink Target 96Infectious DiseasesTechnical EvaluationPlasma

PLOS Neglected Tropical Diseases, 2025
Transcriptional and cytokine signatures of Mycobacterium abscessus complex pulmonary disease during disease progression and treatment

Syenina A., Tan Y., Tng D. et al.

Olink Target 48Respiratory DiseasesInfectious DiseasesPatient StratificationPlasma

Brain, Behavior, and Immunity, 2025
CCL25 in the cerebrospinal fluid is negatively correlated with fatigue in chronic pain patients

Rosenström A., Ahmed A., Farinotti A. et al.

Olink Target 96NeurologyPathophysiologyPatient StratificationPlasmaCSF

3195 publications